Show simple item record

dc.contributor.authorZarei, O
dc.contributor.authorRezania, S
dc.contributor.authorMousavi, A
dc.date.accessioned2018-08-26T08:03:48Z
dc.date.available2018-08-26T08:03:48Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49369
dc.description.abstractApproximately, 15-20% of all cancers worldwide are caused by infectious agents. Understanding the role of infectious agents on cancer development might be useful for developing new approaches to its prevention. Mycoplasma genitalium is a clinically important sexually transmitted pathogen that has been associated with several human diseases. There have been a few studies suggestive of probable roles of Mycoplasma genitalium in cancer development, including prostate and ovarian cancers and lymphomas, but the role of this microorganism like other Mycoplasma species in neoplasia is still conjectural. Considering the prevalence of Mycoplasma genitalium infections and also the emergence of resistant strains, Mycoplasma genitalium needs more attention in the infectious agent cancer-causing research area.
dc.language.isoEnglish
dc.relation.ispartofASIAN PACIFIC JOURNAL OF CANCER PREVENTION
dc.subjectMycoplasma
dc.subjectcancer
dc.subjectinfectious etiology
dc.subjectinfection
dc.titleMycoplasma genitalium and Cancer: A Brief Review
dc.typeReview
dc.citation.volume14
dc.citation.issue6
dc.citation.spage3425
dc.citation.epage3428
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.7314/APJCP.2013.14.6.3425


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record